Prosecution Insights
Prosecution Insights
5 pending office actions • 2 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (40%) |
| No statute on record | 3 (60%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FISHER, MELISSA L | 1 | 44.2% | +42.3% |
| KONOPELSKI SNAVEL, SARA ELIZABETH | 1 | 33.3% | +30.0% |
| KOMATSU, LI N | 1 | 59.5% | +70.8% |
| NIEBAUER, RONALD T | 1 | 41.4% | +33.8% |
| BEANE, RANDALL L | 1 | 32.5% | +37.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18097077 | PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES | NIEBAUER, RONALD T | 98d overdue |
| 18018482 | CONJUGATED HEPCIDIN MIMETICS | KOMATSU, LI N | 66d overdue |
| 17788179 | Methods for Treating Inflammatory Bowel Diseases with alpha4beta7 Integrin Antagonists | BEANE, RANDALL L | 58d overdue |
| 18139254 | METHODS FOR TREATING INFLAMMATORY BOWEL DISEASES WITH a4B7 INTEGRIN ANTAGONISTS | FISHER, MELISSA L | 44d overdue |
| 18018481 | CONJUGATED HEPCIDIN MIMETICS | KONOPELSKI SNAVEL, SARA ELIZABETH | 28d overdue |
| Art Unit | Apps |
|---|---|
| 1658 | 4 |
| 1654 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18139254 | METHODS FOR TREATING INFLAMMATORY BOWEL DISEASES WITH a4B7 INTEGRIN ANTAGONISTS | FISHER, MELISSA L | 1658 | §103 | Non-Final OA | 44d overdue | Pending | Apr 25, 2023 |
| 18018481 | CONJUGATED HEPCIDIN MIMETICS | KONOPELSKI SNAVEL, SARA ELIZABETH | 1658 | §103 | Non-Final OA | 28d overdue | Pending | Jan 27, 2023 |
| 18018482 | CONJUGATED HEPCIDIN MIMETICS | KOMATSU, LI N | 1658 | Other | Non-Final OA | 66d overdue | Pending | Jan 27, 2023 |
| 18097077 | PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES | NIEBAUER, RONALD T | 1658 | Other | Final Rejection | 98d overdue | Pending | Jan 13, 2023 |
| 17788179 | Methods for Treating Inflammatory Bowel Diseases with alpha4beta7 Integrin Antagonists | BEANE, RANDALL L | 1654 | Other | Non-Final OA | 58d overdue | Pending | Jun 22, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial